IMPPAT Phytochemical information: 
Arbutin

Arbutin
Clinical trials
Public title (as per ICTRP)Scientific title (as per ICTRP)Trial identifier
A randomized, split-face, comparative clinical study on the efficacy of Eucerin ultraWHITE+ spotless and the combination of 2%hydroquinone and 4%arbutin for the treatment of skin hyperpigmentationA randomized, split-face, comparative clinical study on the efficacy of Eucerin ultraWHITE+ spotless and the combination of 2%hydroquinone and 4%arbutin for the treatment of skin hyperpigmentationTCTR20190614008
Picosecond Laser combined with a Cream Formulation Containing Levorotatory Vitamin C 10% and Arbutin 4% for Treatment of MelasmaPicosecond Laser combined with a Cream Formulation Containing Levorotatory Vitamin C 10% and Arbutin 4% for Treatment of MelasmaChiCTR2100042939
Effects of an herbal mixture plus D-mannose on the prevention of recurrent uncomplicated cystitisStudy on the effectiveness of an innovative combination of plant extracts (Berberine, Arbutin, Birch) that administered in conjunction with the D-mannose, for the prevention of recurrent urinary tract infectionsISRCTN13017713
sebum reduction & blemishes control activityA Consumer study to check the a sebum reduction and blemishes control activity of Asaya 10 percent Niacinamide and 1 percent Alpha Arbutin Serum - NILCTRI/2024/10/074954
Effectiveness and safety of a mixture of diosmin, coumarin and arbutin (LinfadrenĀ®) in addition to conventional treatment, in the management of patients with persistent hand edema following trauma or surgery of distal forearm or hand. A randomized controlled trial.Effectiveness and safety of a mixture of diosmin, coumarin and arbutin (LinfadrenĀ®) in addition to conventional treatment, in the management of patients with persistent hand edema following trauma or surgery of distal forearm or hand. A randomized controlled trial.ACTRN12618001033235
evaluating effectiveness of combination therapy with niosomal kojic acid and arbutin in melasmaComparision of niosomal kojic acid and arbutin with hydroquinone 4% in the treatment of melasma patientsIRCT20200623047891N1